From: An in vitro study elucidating the synergistic effects of aqueous cinnamon extract and an anti-TNF-α biotherapeutic: implications for a complementary and alternative therapy for non-responders
Trans-cinnamaldehyde concentration
Infliximab EC50
[ng/mL]
p-values
Control
1.234
NA
40 µg/mL
0.9498
0.0007
32 µg/mL
0.9703
0.0008